41408-19-9

Basic information

• Product Name: 2-methyl-2-(4-methylpent-3-en-1-yl)-7-propyl-2H-chromen-5-ol
• Synonyms: 2H-1-Benzopyran-5-ol, 2-methyl-2-(4-methyl-3-pentenyl)-7-propyl-
• CAS NO: 41408-19-9
• Molecular Formula: C₁₉H₂₆O₂
• Molecular Weight: 286.4085
• Mol File: 41408-19-9.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 401.4°C at 760 mmHg
• Flash Point: 164.2°C
• Density: 1.009g/cm³
• Vapor Pressure: 5.1E-07mmHg at 25°C
• Refractive Index: 1.532
• CAS DataBase Reference: 2-methyl-2-(4-methylpent-3-en-1-yl)-7-propyl-2H-chromen-5-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-methyl-2-(4-methylpent-3-en-1-yl)-7-propyl-2H-chromen-5-ol(41408-19-9)
• EPA Substance Registry System: 2-methyl-2-(4-methylpent-3-en-1-yl)-7-propyl-2H-chromen-5-ol(41408-19-9)

Safety Data

• Hazardous Substances Data: 41408-19-9(Hazardous Substances Data)

Upstream product

• 500-49-2 5-propyl-1,3-benzenediol 
• 5392-40-5 (E/Z)-3,7-dimethyl-2,6-octadienal 

Downstream Products

• 33745-21-0 cannabivarin 

Relevant articles and documents

CHROMENIC PHYTOCANNABINOIDS, THEIR SYNTHESIS AND USE IN TREATMENT OR PREVENTION OF DISEASE

The present invention relates to a compound of the formula (I) or a solvate or co-crystal thereof wherein: - R is selected from the group consisting of: a C1-C6 alkyl, a C2-C8 alkenyl moiety, a C4-C12 dienyl or a C6-C18 trienyl moiety; - R1 is a C1-C6 alkyl moiety; - R2 is selected from the group consisting of: H and a C1-C6 alkyl moiety; - R3 is selected from the group consisting of: H and a C1-C6 alkyl moiety; - R4 is selected from the group consisting of: H, a C1-C6 alkyl moiety and a benzyl moiety. The present invention also relates to a process for producing said compound of the formula (I), or a solvate or co-crystal thereof, as well as a pharmaceutical composition comprising said compound of the formula (I), or a solvate or co-crystal thereof and at least one excipient. The present invention also relates to a compound of the formula (I), or a solvate or co-crystal thereof, for use in the treatment or prevention of a disease or condition.

Cannabis. X. The isolation and structures of four new propyl cannabinoid acids, tetrahydrocannabivarinic acid, cannabidivarinic acid, cannabichromevarinic acid and cannabigerovarinic acid, from Thai cannabis, Meao Variant

Four new cannabinoids acids, tetrahydrocannabivarinic acid, cannabidivarinic acid, cannabichromevarinic acid and cannabigerovarinic acid were isolated from Thai Cannabis 'Meao variant' and these structures were elucidated on the basis of chemical and spectral data. This is the first example of the isolation of propyl cannabinoid acid from Cannabis.